$12M capital infusion pumps Prairie Village-based Artio Medical to $46M in funding
April 29, 2021 | Startland News Staff
A Johnson County medical device company announced Thursday the closing of an additional $12 million tranche of Series A financing — advancing the startup’s tech toward clinical study and commercialization with the backing of a leading Kansas City real estate developer.
“We are thrilled to close this round of financing with strong support from existing investors who share our mission to provide better patient outcomes,” said Dr. F. Nicholas Franano, president and CEO of Artio. “The Artio team is focused on the road ahead as we advance multiple development programs and prepare for commercialization of our first product.”
The funding brings Artio’s total capital raised to $46 million, Franano said.
Click here to see why Artio Medical, formerly also known as Metactive, was named one of Startland News’ Kansas City Startups to Watch in 2019.
Led by existing investors Sarah Hagedorn and Nathaniel Hagedorn — founder and CEO of Northpoint Development — the deal announced Thursday will be used to accelerate the development of Artio’s peripheral vascular product pipeline, which is highly complementary with significant overlap in call points and procedures, the company said.
The Amplifi Vein Dilation System, which aims to prepare hemodialysis patients for successful vascular access site creation, has shown promising results in initial clinical testing, Artio said in a press release. And the Solus Gold Embolization Device comprises a low-profile, flexible catheter assembly and a non-porous, gold balloon-like implant and is designed for precise placement and immediate vessel occlusion. The device has shown exceptional performance in preclinical testing, the company said.
“Nick has built a broad, diverse portfolio of highly innovative products at Artio and is assembling a world-class team to develop and commercialize them,” said Nathaniel Hagedorn. “We were pleased to have the opportunity to lead this round of financing and to invest additional capital to move the company and its mission forward.”
Just over a year ago, Artio announced its rebranding from “Metactive” and a fresh $8.8 million round to help boost its best-in-class products for the peripheral vascular and neurovascular markets.
Click here to learn more about Artio Medical.
Featured Business
2021 Startups to Watch
stats here
Related Posts on Startland News
GEW hopes to spark innovation, connections among entrepreneurs
Global Entrepreneurship Week is about helping businesses that start in Kansas City stay in Kansas City, Jenny Miller said. And it’s for more than the traditional “startup” crowd, the network builder at KCSourceLink said. “GEWKC connects people who may not identify as ‘entrepreneurs’ – those who may think of themselves as makers, creators, freelancers, artists,…
Hip hop entrepreneur: Rap stardom isn’t the only way to a paycheck
Music is everything, Kartez Marcel said. It’s an avenue to express anger and hurt in a positive way. It’s a way to heal. And for aspiring entrepreneurs, it’s an opportunity to earn a paycheck even if they aren’t destined for on-stage superstardom, said Marcel, a Kansas City rapper and hip hop industry mentor. “Everybody wants…
FAQ: Is it all hype? Tunneling into Missouri’s chances for Hyperloop
Virgin Hyperloop One might seem like a pipe dream. But the prospect of Kansas Citians reaching St. Louis in only 23 minutes is more realistic than many think. In fact, according to recent reports, Missouri has at least a 20 percent chance at landing Hyperloop, a yet-to-be-realized transportation system that moves people and freight at…
CEO: Infusion Express $13.5M round proves realistic investment can come to KC
When Kansas City-based Infusion Express closed a $13.5 million Series B round earlier this month with McKesson Ventures as its lead investor, the move wasn’t a fluke, Don Peterson said. “If you build something really great, the money will find you,” said Peterson, CEO of Infusion Express. “I didn’t call McKesson, they called me. When…